Yahoo
NasdaqGS - Delayed Quote USD

Organigram Global Inc. (OGI)

0.9331 -0.0274 (-2.85%)
At close: October 30 at 4:00:00 PM EDT
Chart Range Bar
Loading chart for OGI
  • Previous Close 0.9605
  • Open 0.9510
  • Bid 0.9200 x 500
  • Ask 1.2200 x 200
  • Day's Range 0.9300 - 0.9699
  • 52 Week Range 0.8530 - 2.2400
  • Volume 198,810
  • Avg. Volume 863,940
  • Market Cap (intraday) 134.509M
  • Beta (5Y Monthly) 1.91
  • PE Ratio (TTM) 2.17
  • EPS (TTM) 0.4300
  • Earnings Date Aug 11, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est --
  • Motley Fool Rating Bearish

Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings and dried flowers to other licensed producers. It sells cannabis products to wholesale and retail channels in the recreational and medical cannabis regimes, as well as through online. Organigram Global Inc. was formerly known as Organigram Holdings Inc. and changed its name to Organigram Global Inc. in March 2025. The company is headquartered in Toronto, Canada.

www.organigram.ca

1,139

Full Time Employees

September 30

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

OGI
45.11%
S&P/TSX Composite index (^GSPTSE)
11.78%

1-Year Return

OGI
41.31%
S&P/TSX Composite index (^GSPTSE)
18.03%

3-Year Return

OGI
10.28%
S&P/TSX Composite index (^GSPTSE)
88.90%

5-Year Return

OGI
89.44%
S&P/TSX Composite index (^GSPTSE)
69.32%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 105.78M
Earnings 105.54M
Profit Margin 99.77%

Q3

FY25

Q4

FY25

Q1

FY26

Q3

FY26

0
50M
100M
0.0%
50.0%

Analyst Insights

View More

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    28.02%

  • Return on Assets (ttm)

    -0.60%

  • Return on Equity (ttm)

    17.56%

  • Revenue (ttm)

    309.18M

  • Net Income Avi to Common (ttm)

    86.62M

  • Diluted EPS (ttm)

    0.4300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    11.67M

  • Total Debt/Equity (mrq)

    5.69%

  • Levered Free Cash Flow (ttm)

    -1.25M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: